ACE and Alzheimer disease: Genetics may also play a role in explaining the heterogeneity of observed effects, as one study found that APOE ε4 carriers with specific ACE genotypes benefitted more from ACE-Is in reducing cognitive decline than did non-carriers [84]; another study suggested that APOE and ACE genotypes may interact to confer risk of AD [85].